Restricted Water Diffusibility as Measured by Diffusion-weighted MR Imaging and Choline Uptake in 11C-Choline PET/CT are Correlated in Pelvic Lymph Nodes in Patients with Prostate Cancer
- First Online:
- 278 Downloads
11C-Choline-positron emission tomography (PET)/computed tomography (CT) is increasingly used in patients with prostate cancer. Another promising technique for assessment of tumor biology is diffusion-weighted MR imaging (DWI). The aim of the study was to compare the functional parameters standardized uptake value (SUV) in PET and apparent diffusion coefficient (ADC) value in DWI of lymph nodes in prostate cancer patients.
Fourteen patients with prostate cancer underwent DWI at 1.5T and 11C-Choline-PET/CT. ADC values and SUVs of all lymph nodes larger than 5 mm (n = 55) were compared by using linear regression analysis. Performance of DWI and 11C-Choline PET was assessed by receiver operator characteristic curve analysis using histopathology or clinical follow-up as standard of reference.
ADC values and SUV showed a moderate but highly significant inverse correlation (r = −0.5144, p < 0.0001). In lymph nodes with low ADC values, the dispersion of SUV was more pronounced. Moreover, a highly significant difference was observed for mean ADC values and SUV in lymph nodes considered as benign or malignant by follow-up/histopathology (ADC 1.60 ± 0.24 vs. 1.09 ± 0.23 × 10−3 mm2/s; SUV 1.82 ± 0.57 vs. 4.68 ± 03.12; p < 0.0001, respectively).
These pilot data propose the ADC value in DWI as a new potential imaging biomarker which might provide additional information on tumor pathophysiology compared to the SUV in 11C-Choline PET/CT.
Key words11C-Choline PET/CT Diffusion-weighted MR imaging Comparison Lymph node metastases Prostate cancer
- 26.Thoeny H, Triantafyllou M, Birkhaeuser F et al (2009) Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 55(4):761–769PubMedCrossRefGoogle Scholar
- 28.Klerkx W, Mali W, Peter HA et al (2009) Observer variation of magnetic resonance imaging and diffusion weighted imaging in pelvic lymph node detection. Eur J RadiolGoogle Scholar
- 34.Holzapfel K, Bruegel M, Eiber M et al (2009) Characterization of small (</=10 mm) focal liver lesions: value of respiratory-triggered echo-planar diffusion-weighted MR imaging. Eur J RadiolGoogle Scholar
- 49.Nuñez R, Macapinlac HA, Yeung HWD et al (2002) Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 43:46–55Google Scholar
- 52.Picchio M, Crivellaro C, Giovacchini G, Gianolli L, Messa C (2009) PET-CT for treatment planning in prostate cancer. The Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical. Chemistry and Biology 53:245–268Google Scholar
- 53.Torizuka T, Kanno T, Futatsubashi M et al (2003) Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 44:1051–1056Google Scholar
- 57.Farsad M, Schiavina R, Castellucci P et al (2005) Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 46:1642–1649Google Scholar